Association of renin BglI polymphism with essential hypertension: a meta-analysis involving 1811 cases and 1626 controls

Clin Exp Hypertens. 2010;32(7):431-8. doi: 10.3109/10641961003686419. Epub 2010 Oct 6.

Abstract

In an effort to clarify association of an intronic polymorphism BglI in a renin gene with essential hypertension, we performed a meta-analysis of the case-control association studies. Publications in the English language and human subjects were searched in PubMed and EMBASE as of July 10, 2009. A fixed-effects model was applied to pool data in the absence of between-studies heterogeneity, and a random-effects model otherwise. Data and study quality were assessed in duplicate. Publication bias was evaluated using the fail-safe number. From three studies with four populations including 1811 patients with essential hypertension and 1626 controls, we found a significant association of renin BglI B with an increased risk for essential hypertension (OR = 1.25; 95% CI, 1.11 to 1.41; P = 0.0002). In addition, significance persisted after assuming the dominant (OR = 1.30; 95% CI, 1.13 to 1.51; P = 0.0004) mode of inheritance, while no significance was observed for the recessive mode (OR = 1.46; 95% CI, 0.82 to 2.60; P = 0.20). The fail-safe number at the level of 0.05 supported these significant associations. In sum, our meta-analysis expands previous findings by showing that the presence of renin BglI B allele is associated with an increased risk in developing essential hypertension, and this effect might act in a dominant mode of inheritance. Further studies are warranted to fully address questions about the etiologic mechanisms of this positive association.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles
  • Blood Pressure / genetics
  • Female
  • Genetic Association Studies
  • Humans
  • Hypertension* / etiology
  • Hypertension* / genetics
  • Inheritance Patterns
  • Male
  • Models, Statistical
  • Odds Ratio
  • Polymorphism, Single Nucleotide*
  • Renin* / genetics
  • Renin-Angiotensin System / genetics
  • Risk Assessment
  • Vasoconstriction / genetics

Substances

  • Renin